Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
GlobalData on MSN
Stereotaxis secures FDA approval for ablation catheter
The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback